MedPath

Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer

Phase 3
Completed
Conditions
Colorectal Cancer
Interventions
Drug: capecitabine
Drug: oxaliplatin
Procedure: conventional surgery
Procedure: neoadjuvant therapy
Radiation: radiation therapy
Registration Number
NCT00227747
Lead Sponsor
UNICANCER
Brief Summary

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Drugs used in chemotherapy, such as capecitabine and oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. Giving radiation therapy together with combination chemotherapy before surgery may shrink the tumor so it can be removed. It is not yet known whether giving radiation therapy together with capecitabine is more effective with or without oxaliplatin before surgery in treating rectal cancer.

PURPOSE: This randomized phase III trial is studying radiation therapy, capecitabine, and oxaliplatin to see how well they work compared to radiation therapy and capecitabine in treating patients who are undergoing surgery for stage II or stage III rectal cancer.

Detailed Description

OBJECTIVES:

Primary

* Compare the efficacy of neoadjuvant chemoradiotherapy comprising radiotherapy and capecitabine with vs without oxaliplatin followed by total mesorectal excision, in terms of the rate of complete surgical resection, in patients with resectable stage II or III rectal cancer.

Secondary

* Compare overall and disease-free survival of patients treated with these regimens.

* Compare clinical tumor response in patients treated with these regimens.

* Compare acute and late toxicity of these regimens in these patients.

* Determine biological parameters that predict tumor response and treatment-related toxicity in patients treated with these regimens.

* Compare sphincter preservation and function in patients treated with these regimens.

OUTLINE: This is a randomized, controlled, multicenter study. Patients are randomized to 1 of 2 treatment arms.

* Arm I: Patients undergo radiotherapy once daily 5 days a week and receive capecitabine once daily 5 days a week in weeks 1-5.

* Arm II: Patient undergo radiotherapy and receive capecitabine as in arm I. Patients also receive oxaliplatin once weekly in weeks 1-5.

All patients undergo total mesorectal excision 6 weeks after completion of chemoradiotherapy.

PROJECTED ACCRUAL: A total of 590 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
598
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Radiothérapie + Xeloxcapecitabine-
Radiothérapie + Xeloxoxaliplatin-
Radiothérapie + Xeloxconventional surgery-
Radiothérapie + Xeloxneoadjuvant therapy-
Radiothérapie + Xeloxradiation therapy-
Radiothérapie + Capécitabinecapecitabine-
Radiothérapie + Capécitabineconventional surgery-
Radiothérapie + Capécitabineneoadjuvant therapy-
Radiothérapie + Capécitabineradiation therapy-
Primary Outcome Measures
NameTimeMethod
Rate of complete surgical resection
Secondary Outcome Measures
NameTimeMethod
Overall survival
Disease-free survival
Sphincter preservation
Sphincter function
Biological parameters that predict tumor response and treatment-related toxicity
Acute and late toxicity

Trial Locations

Locations (68)

Centre Regional Francois Baclesse

🇫🇷

Caen, France

Hopital Drevon

🇫🇷

Dijon, France

Polyclinique Bordeaux Nord Aquitaine

🇫🇷

Bordeaux, France

Centre Hospitalier Pierre Oudot

🇫🇷

Bourgoin-Jallieu, France

Centre Hospitalier de Gap

🇫🇷

Gap, France

Centre Hospitalier d'Abbeville

🇫🇷

Abbeville, France

Hopital Duffaut

🇫🇷

Avignon, France

Clinique Tivoli

🇫🇷

Bordeaux, France

Polyclinique du Val de Loire

🇫🇷

Nevers, France

Centre Hospitalier Universitaire Henri Mondor

🇫🇷

Creteil, France

Clinique Victor Hugo

🇫🇷

Le Mans, France

Centre Hospitalier Docteur Duchenne

🇫🇷

Boulogne Sur Mer, France

Hopital Jean Bernard

🇫🇷

Limoges, France

Clinique Sainte Marie

🇫🇷

Chalon Sur Saone, France

Clinique Clementville

🇫🇷

Montpellier, France

Centre Hospitalier - Pau

🇫🇷

Pau, France

Hopital Europeen Georges Pompidou

🇫🇷

Paris, France

Clinique Pasteur - Toulouse

🇫🇷

Toulouse, France

Clinique Saint - Pierre

🇫🇷

Perpignan, France

Centre Rene Huguenin

🇫🇷

Saint Cloud, France

Centre d'Oncologie Saint-Yves

🇫🇷

Vannes, France

Hopital Louis Pasteur

🇫🇷

Colmar, France

Hopital Du Bocage

🇫🇷

Dijon, France

Clinique Sainte-Marguerite

🇫🇷

Hyeres, France

Centre Hospitalier Departemental

🇫🇷

La Roche Sur Yon, France

Centre Oscar Lambret

🇫🇷

Lille, France

Centre Hospital Regional Universitaire de Limoges

🇫🇷

Limoges, France

Clinique J. B. Menis

🇫🇷

Macon, France

Centre Leon Berard

🇫🇷

Lyon, France

CHU de la Timone

🇫🇷

Marseille, France

Hopital Notre-Dame de Bon Secours

🇫🇷

Metz, France

Centre Hospitalier Intercommunal Le Raincy - Montfermeil

🇫🇷

Montfermeil, France

Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle

🇫🇷

Montpellier, France

Centre Regional Rene Gauducheau

🇫🇷

Nantes-Saint Herblain, France

Clinique Hartmann

🇫🇷

Neuilly sur Seine, France

C.H.U. de Nimes - Groupe Hospitals-Universitaire Caremeau

🇫🇷

Nimes, France

CHR D'Orleans - Hopital de la Source

🇫🇷

Orleans, France

Hopital Saint-Louis

🇫🇷

Paris, France

CHU Pitie-Salpetriere

🇫🇷

Paris, France

Hopital Tenon

🇫🇷

Paris, France

Centre Hospitalier Lyon Sud

🇫🇷

Pierre Benite, France

Institut Jean Godinot

🇫🇷

Reims, France

Centre Eugene Marquis

🇫🇷

Rennes, France

CHU - Robert Debre

🇫🇷

Reims, France

Polyclinique De Courlancy

🇫🇷

Reims, France

Centre Hospitalier de Rodez

🇫🇷

Rodez, France

Clinique Armoricaine De Radiologie

🇫🇷

Saint Brieuc, France

Institut de Cancerologie de la Loire

🇫🇷

Saint Priest en Jarez, France

Centre Paul Strauss

🇫🇷

Strasbourg, France

Centre Alexis Vautrin

🇫🇷

Vandoeuvre-les-Nancy, France

Centre Hospitalier

🇫🇷

Altkirch, France

Institut Bergonie

🇫🇷

Bordeaux, France

Hopital de Beziers

🇫🇷

Beziers, France

Centre Hospitalier de Blois

🇫🇷

Blois, France

Hopital Saint Andre

🇫🇷

Bordeaux, France

CHU de Caen

🇫🇷

Caen, France

Hopital Robert Boulin

🇫🇷

Libourne, France

Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes

🇫🇷

Marseille, France

Centre Hospitalier General Andre Boulloche

🇫🇷

Montbeliard, France

Centre Hospitalier de Mulhouse

🇫🇷

Mulhouse, France

Clinique Plein Ciel

🇫🇷

Mougins, France

Centre Antoine Lacassagne

🇫🇷

Nice, France

Hopital Bichat - Claude Bernard

🇫🇷

Paris, France

Institut Gustave Roussy

🇫🇷

Villejuif, France

Institut Claudius Regaud

🇫🇷

Toulouse, France

Polyclinique des Quatre Pavillons

🇫🇷

Lormont, France

Institut Sainte Catherine

🇫🇷

Avignon, France

Centre Hospitalier General

🇫🇷

Longjumeau, France

© Copyright 2025. All Rights Reserved by MedPath